About Clinical Laserthermia Systems AB 
Clinical Laserthermia Systems AB
Pharmaceuticals & Biotechnology
Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.
Company Coordinates 
Company Details
Medicon Village, Scheelevagen 2 , LUND None : 223 81
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Hans von Celsing
Chairman of the Board
Mr. Arne Ferstad
Director
Mr. Rolf Kiessling
Director
Mr. Karl-Goran Tranberg
Director
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
Pharmaceuticals & Biotechnology
SEK 241 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.24
-64.37%
3.58






